• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Siva 1抑制宫颈癌进展及其临床预后意义。

Siva 1 Inhibits Cervical Cancer Progression and Its Clinical Prognosis Significance.

作者信息

Liu Ting, Ma Yifei, Wang Zhiling, Zhang Wenjing, Yang Xingsheng

机构信息

Department of Gynecology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, People's Republic of China.

Department of Obstetrics and Gynecology, Jinan Central Hospital Affiliated to Shandong University, Jinan, Shandong 250013, People's Republic of China.

出版信息

Cancer Manag Res. 2020 Jan 15;12:303-311. doi: 10.2147/CMAR.S232994. eCollection 2020.

DOI:10.2147/CMAR.S232994
PMID:32021444
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6970243/
Abstract

BACKGROUND

Cervical cancer is the second most common female malignancies. But the exact etiology of cervical cancer is still under investigation. Recent observations revealed that the loss expression of Siva 1 was related to several different types of tumors. It could play an indispensable role in both exogenous and endogenous apoptotic signaling pathways. Nevertheless, the relationship between Siva 1 expression and cervical cancer progression has not yet been fully clarified. This study aimed to explore the functional role of Siva1 in cervical cancer.

MATERIALS AND METHODS

In this present experiment, expression of Siva 1 was detected in 87 cervical cancer, 34 CIN and 20 normal samples by immunohistochemistry. The correlation of Siva 1 expression and overall survival times (OS) was analyzed by Kaplan-Meier analysis. We up-regulated the expression of Siva 1 by plasmid pCMV3-Siva 1 in C33A cells. CCK8, flow cytometry, wound-healing, and transwell assays were performed to examine the influences of Siva 1 expression on cell proliferation, apoptosis, migration and invasion.

RESULTS

The expression of Siva 1 was decreased in cervical cancer tissues compared with CIN and normal tissues. In addition, the Siva 1 immunoreactivity was significantly associated with tumor differentiation. Patients with Siva 1 negative staining exhibited a significantly decreased overall survival. Then, we established stable Siva 1 ectopic expression cells, and we found that elevated expression of Siva 1 promoted apoptosis, inhibited proliferation, and suppressed migration and invasion of cervical cancer cells.

CONCLUSION

The present study revealed a crucial role of Siva 1 in tumor progression and it may be a valuable prognostic indicator of cervical cancer.

摘要

背景

宫颈癌是第二常见的女性恶性肿瘤。但其确切病因仍在研究中。最近的观察表明,Siva 1的表达缺失与几种不同类型的肿瘤有关。它在外源性和内源性凋亡信号通路中都可能发挥不可或缺的作用。然而,Siva 1表达与宫颈癌进展之间的关系尚未完全阐明。本研究旨在探讨Siva1在宫颈癌中的功能作用。

材料与方法

在本实验中,通过免疫组织化学检测了87例宫颈癌、34例宫颈上皮内瘤变(CIN)和20例正常样本中Siva 1的表达。采用Kaplan-Meier分析方法分析Siva 1表达与总生存时间(OS)的相关性。我们通过质粒pCMV3-Siva 1在C33A细胞中上调Siva 1的表达。进行CCK8、流式细胞术、伤口愈合和Transwell实验,以检测Siva 1表达对细胞增殖、凋亡、迁移和侵袭的影响。

结果

与CIN和正常组织相比,宫颈癌组织中Siva 1的表达降低。此外,Siva 1免疫反应性与肿瘤分化显著相关。Siva 1阴性染色的患者总生存率显著降低。然后,我们建立了稳定的Siva 1异位表达细胞,发现Siva 1表达升高可促进宫颈癌细胞凋亡、抑制增殖并抑制其迁移和侵袭。

结论

本研究揭示了Siva 1在肿瘤进展中的关键作用,它可能是宫颈癌一个有价值的预后指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e502/6970243/840ec5786de7/CMAR-12-303-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e502/6970243/c1b39d873453/CMAR-12-303-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e502/6970243/d78161a78694/CMAR-12-303-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e502/6970243/fb8a2e35192d/CMAR-12-303-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e502/6970243/d744e4ed7b0e/CMAR-12-303-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e502/6970243/840ec5786de7/CMAR-12-303-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e502/6970243/c1b39d873453/CMAR-12-303-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e502/6970243/d78161a78694/CMAR-12-303-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e502/6970243/fb8a2e35192d/CMAR-12-303-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e502/6970243/d744e4ed7b0e/CMAR-12-303-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e502/6970243/840ec5786de7/CMAR-12-303-g0005.jpg

相似文献

1
Siva 1 Inhibits Cervical Cancer Progression and Its Clinical Prognosis Significance.Siva 1抑制宫颈癌进展及其临床预后意义。
Cancer Manag Res. 2020 Jan 15;12:303-311. doi: 10.2147/CMAR.S232994. eCollection 2020.
2
Inhibition of apoptosis-regulatory protein Siva-1 reverses multidrug resistance in gastric cancer by targeting PCBP1.抑制凋亡调节蛋白 Siva-1 通过靶向 PCBP1 逆转胃癌多药耐药。
Oncol Res. 2023 Feb 9;30(6):277-288. doi: 10.32604/or.2022.027301. eCollection 2022.
3
Siva 1 inhibits proliferation, migration and invasion by phosphorylating Stathmin in ovarian cancer cells.Siva 1通过磷酸化卵巢癌细胞中的Stathmin来抑制细胞增殖、迁移和侵袭。
Oncol Lett. 2017 Aug;14(2):1512-1518. doi: 10.3892/ol.2017.6307. Epub 2017 Jun 2.
4
Siva‑1 regulates multidrug resistance of gastric cancer by targeting MDR1 and MRP1 via the NF‑κB pathway.Siva-1 通过 NF-κB 通路靶向 MDR1 和 MRP1 调节胃癌的多药耐药性。
Mol Med Rep. 2020 Aug;22(2):1558-1566. doi: 10.3892/mmr.2020.11211. Epub 2020 Jun 3.
5
Plumbagin inhibits proliferation and induces apoptosis of hepatocellular carcinoma by downregulating the expression of SIVA.白花丹醌通过下调SIVA的表达抑制肝癌细胞增殖并诱导其凋亡。
Drug Des Devel Ther. 2019 Apr 23;13:1289-1300. doi: 10.2147/DDDT.S200610. eCollection 2019.
6
SIVA-1 enhances acquired chemotherapeutic drug resistance of gastric cancer in vivo by regulating the ARF/MDM2/p53 pathway.SIVA-1通过调节ARF/MDM2/p53通路增强胃癌在体内获得性化疗耐药性。
Heliyon. 2024 Jan 11;10(2):e24394. doi: 10.1016/j.heliyon.2024.e24394. eCollection 2024 Jan 30.
7
The miR-133b/brefeldin A-inhibited guanine nucleotide-exchange protein 1 (ARFGEF1) axis represses proliferation, invasion, and migration in cervical cancer cells.miR-133b/布雷菲德菌素 A 抑制鸟嘌呤核苷酸交换因子 1(ARFGEF1)轴抑制宫颈癌细胞的增殖、侵袭和迁移。
Bioengineered. 2022 Feb;13(2):3323-3332. doi: 10.1080/21655979.2022.2027063.
8
Study on the Role of EPHB6 in Inhibiting the Malignant Progression of Cervical Cancer C33A Cells by Binding to CBX7.EPHB6通过与CBX7结合抑制宫颈癌C33A细胞恶性进展的作用研究
Cell Biochem Biophys. 2024 Dec;82(4):3703-3713. doi: 10.1007/s12013-024-01458-8. Epub 2024 Sep 26.
9
Dynamin 3 overexpression suppresses the proliferation, migration and invasion of cervical cancer cells.发动蛋白3过表达抑制宫颈癌细胞的增殖、迁移和侵袭。
Oncol Lett. 2021 Jul;22(1):524. doi: 10.3892/ol.2021.12785. Epub 2021 May 12.
10
PM2.5 exposure induces alveolar epithelial cell apoptosis and causes emphysema through p53/Siva-1.PM2.5 暴露诱导肺泡上皮细胞凋亡,并通过 p53/Siva-1 导致肺气肿。
Eur Rev Med Pharmacol Sci. 2020 Apr;24(7):3943-3950. doi: 10.26355/eurrev_202004_20863.

引用本文的文献

1
SIVA-1 interaction with PCBP1 serves as a predictive biomarker for cisplatin sensitivity in gastric cancer and its inhibitory effect on tumor growth .SIVA-1与PCBP1的相互作用作为胃癌顺铂敏感性的预测生物标志物及其对肿瘤生长的抑制作用。
J Cancer. 2024 Jun 11;15(13):4301-4312. doi: 10.7150/jca.92963. eCollection 2024.
2
Mutation of SIVA, a candidate metastasis gene identified from clonally related bilateral breast cancers, promotes breast cancer cell spread in vitro and in vivo.SIVA 是从克隆相关的双侧乳腺癌中鉴定出的候选转移基因,其突变可促进乳腺癌细胞在体外和体内的扩散。
PLoS One. 2024 May 9;19(5):e0302856. doi: 10.1371/journal.pone.0302856. eCollection 2024.
3

本文引用的文献

1
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
2
Foxp3 is correlated with VEGF-C expression and lymphangiogenesis in cervical cancer.Foxp3 与宫颈癌中的 VEGF-C 表达和淋巴管生成相关。
World J Surg Oncol. 2017 Sep 18;15(1):173. doi: 10.1186/s12957-017-1221-5.
3
Siva 1 inhibits proliferation, migration and invasion by phosphorylating Stathmin in ovarian cancer cells.
Targeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studies.
癌症中靶向p53信号通路:分子机制与临床研究
MedComm (2020). 2023 May 28;4(3):e288. doi: 10.1002/mco2.288. eCollection 2023 Jun.
4
FAIM-L - SIVA-1: Two Modulators of XIAP in Non-Apoptotic Caspase Function.FAIM-L - SIVA-1:非凋亡性半胱天冬酶功能中XIAP的两种调节因子
Front Cell Dev Biol. 2022 Jan 10;9:826037. doi: 10.3389/fcell.2021.826037. eCollection 2021.
5
A Personalized Genomics Approach of the Prostate Cancer.前列腺癌的个性化基因组学方法
Cells. 2021 Jun 30;10(7):1644. doi: 10.3390/cells10071644.
6
Siva‑1 regulates multidrug resistance of gastric cancer by targeting MDR1 and MRP1 via the NF‑κB pathway.Siva-1 通过 NF-κB 通路靶向 MDR1 和 MRP1 调节胃癌的多药耐药性。
Mol Med Rep. 2020 Aug;22(2):1558-1566. doi: 10.3892/mmr.2020.11211. Epub 2020 Jun 3.
Siva 1通过磷酸化卵巢癌细胞中的Stathmin来抑制细胞增殖、迁移和侵袭。
Oncol Lett. 2017 Aug;14(2):1512-1518. doi: 10.3892/ol.2017.6307. Epub 2017 Jun 2.
4
Cancer statistics in China, 2015.《中国癌症统计数据 2015》
CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32. doi: 10.3322/caac.21338. Epub 2016 Jan 25.
5
Anticancer activity of recombinant Siva1 protein in human nasopharyngeal carcinoma cell line CNE-2.重组Siva1蛋白在人鼻咽癌CNE-2细胞系中的抗癌活性
Cancer Biomark. 2015;15(6):833-41. doi: 10.3233/CBM-150527.
6
ANKHD1 silencing inhibits Stathmin 1 activity, cell proliferation and migration of leukemia cells.ANKHD1基因沉默可抑制白血病细胞中Stathmin 1的活性、细胞增殖及迁移。
Biochim Biophys Acta. 2015 Mar;1853(3):583-93. doi: 10.1016/j.bbamcr.2014.12.012. Epub 2014 Dec 16.
7
Preliminary research on the expression, purification and function of the apoptotic fusion protein, Sival.凋亡融合蛋白Sival的表达、纯化及功能的初步研究
Asian Pac J Cancer Prev. 2014;15(20):8685-8. doi: 10.7314/apjcp.2014.15.20.8685.
8
Multifaceted functions of Siva-1: more than an Indian God of Destruction.Siva-1 的多面功能:不仅仅是印度破坏之神。
Protein Cell. 2012 Feb;3(2):117-22. doi: 10.1007/s13238-012-2018-5. Epub 2012 Mar 17.
9
Siva1 is a XIAP-interacting protein that balances NFkappaB and JNK signalling to promote apoptosis.Siva1是一种与XIAP相互作用的蛋白质,它平衡核因子κB和JNK信号传导以促进细胞凋亡。
J Cell Sci. 2009 Aug 1;122(Pt 15):2651-61. doi: 10.1242/jcs.049940. Epub 2009 Jul 7.
10
Siva is an apoptosis-selective p53 target gene important for neuronal cell death.西瓦基因是一种对神经元细胞死亡至关重要的凋亡选择性p53靶基因。
Cell Death Differ. 2007 Jul;14(7):1374-85. doi: 10.1038/sj.cdd.4402128. Epub 2007 Apr 20.